209 related articles for article (PubMed ID: 33894201)
1. Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activity.
Usher ET; Sabri N; Rohac R; Boal AK; Mittag T; Showalter SA
J Biol Chem; 2021; 296():100693. PubMed ID: 33894201
[TBL] [Abstract][Full Text] [Related]
2. The Structure of the SPOP-Pdx1 Interface Reveals Insights into the Phosphorylation-Dependent Binding Regulation.
Ostertag MS; Messias AC; Sattler M; Popowicz GM
Structure; 2019 Feb; 27(2):327-334.e3. PubMed ID: 30449689
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase adaptor SPOP in cancer.
Cuneo MJ; Mittag T
FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
[TBL] [Abstract][Full Text] [Related]
4. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
[TBL] [Abstract][Full Text] [Related]
5. Pcif1 modulates Pdx1 protein stability and pancreatic β cell function and survival in mice.
Claiborn KC; Sachdeva MM; Cannon CE; Groff DN; Singer JD; Stoffers DA
J Clin Invest; 2010 Oct; 120(10):3713-21. PubMed ID: 20811152
[TBL] [Abstract][Full Text] [Related]
6. Multiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination.
Pierce WK; Grace CR; Lee J; Nourse A; Marzahn MR; Watson ER; High AA; Peng J; Schulman BA; Mittag T
J Mol Biol; 2016 Mar; 428(6):1256-1271. PubMed ID: 26475525
[TBL] [Abstract][Full Text] [Related]
7. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
[TBL] [Abstract][Full Text] [Related]
8. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.
Jiang Q; Zheng N; Bu L; Zhang X; Zhang X; Wu Y; Su Y; Wang L; Zhang X; Ren S; Dai X; Wu D; Xie W; Wei W; Zhu Y; Guo J
Mol Cancer; 2021 Aug; 20(1):100. PubMed ID: 34353330
[TBL] [Abstract][Full Text] [Related]
9. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.
Zhuang M; Calabrese MF; Liu J; Waddell MB; Nourse A; Hammel M; Miller DJ; Walden H; Duda DM; Seyedin SN; Hoggard T; Harper JW; White KP; Schulman BA
Mol Cell; 2009 Oct; 36(1):39-50. PubMed ID: 19818708
[TBL] [Abstract][Full Text] [Related]
10. Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase.
Errington WJ; Khan MQ; Bueler SA; Rubinstein JL; Chakrabartty A; Privé GG
Structure; 2012 Jul; 20(7):1141-53. PubMed ID: 22632832
[TBL] [Abstract][Full Text] [Related]
11. Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate.
Bunce MW; Boronenkov IV; Anderson RA
J Biol Chem; 2008 Mar; 283(13):8678-86. PubMed ID: 18218622
[TBL] [Abstract][Full Text] [Related]
12. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
[TBL] [Abstract][Full Text] [Related]
13. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP.
van Geersdaele LK; Stead MA; Harrison CM; Carr SB; Close HJ; Rosbrook GO; Connell SD; Wright SC
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1677-84. PubMed ID: 23999291
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
[TBL] [Abstract][Full Text] [Related]
16. Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP.
Sabri N; Cuneo MJ; Marzahn MR; Lee J; Bouchard JJ; Güllülü Ö; Vaithiyalingam S; Borgia MB; Schmit J; Mittag T
J Biol Chem; 2023 Dec; 299(12):105427. PubMed ID: 37926283
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
Wu F; Dai X; Gan W; Wan L; Li M; Mitsiades N; Wei W; Ding Q; Zhang J
Cancer Lett; 2017 Jan; 385():207-214. PubMed ID: 27780719
[TBL] [Abstract][Full Text] [Related]
18. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
[TBL] [Abstract][Full Text] [Related]
19. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
20. SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
Wang J; Zhuang H; Zhang H; Li Q; Cao X; Lin Z; Lin T; Chen X; Ni X; Yang J; Zhao Y; Shen L; Wang H; Zhu J; Ye M; Jin X
Biochem Biophys Res Commun; 2021 Jun; 557():55-61. PubMed ID: 33862460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
